(Q47925759)

6 February 2018

title

Liver disease induced by radioembolization of liver tumors: description and possible risk factors (English)

1 reference

6 February 2018

1 reference

Mercedes Iñarrairaegui

8

1 reference

6 February 2018

José Ignacio Bilbao

10

1 reference

6 February 2018

Ana Chopitea

Ana Chopitea

7

0 references

Javier Arbizu

Javier Arbizu

9

0 references

Iosu Sola

Iosu Sola

4

0 references

Bruno Sangro

Bruno Sangro

1

0 references

Belen Gil-Alzugaray

2

Belen Gil-Alzugaray

1 reference

6 February 2018

Antonio Martínez de la Cuesta

5

Antonio Martinez-Cuesta

1 reference

6 February 2018

author name string

Javier Rodriguez

3

1 reference

6 February 2018

Antonio Viudez

6

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 April 2008

1 reference

6 February 2018

published in

Cancer

1 reference

6 February 2018

volume

112

1 reference

6 February 2018

issue

7

1 reference

6 February 2018

page(s)

1538-1546

1 reference

6 February 2018

Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Glass yttrium-90 microspheres for patients with colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic im

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Hepatic venous outflow obstruction: three similar syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

A review of goodness of fit statistics for use in the development of logistic regression models

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Hepatic toxicity resulting from cancer treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Serum proinflammatory cytokine response in patients with advanced liver tumors following selective internal radiation therapy (SIRT) with (90)Yttrium microspheres

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Tumour dosimetry in human liver following hepatic yttrium-90 microsphere therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Defibrotide, a polydisperse mixture of single-stranded phosphodiester oligonucleotides with lifesaving activity in severe hepatic veno-occlusive disease: clinical outcomes and potential mechanisms of action

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation--role of transjugular intrahepatic portosystemic shunt (TIPS).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Miscellaneous indications for transjugular intrahepatic portosystemic stent-shunt

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23339

7 January 2021

Identifiers

DOI

10.1002/CNCR.23339

1 reference

6 February 2018

1 reference

6 February 2018